Last reviewed · How we verify

NCT03120806

Interrupted Versus Continuous Subcuticular Skin Suturing in Elective Cesarean Section.

Completed NA Last updated 23 December 2021
What this trial tests

NA trial testing Interrupted subcuticular skin closure in Cesarean Section Wound in 169 participants. Completed in 20 December 2017.

Timeline
16 April 2017
Primary endpoint
1 December 2017
20 December 2017

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment169
Start date16 April 2017
Primary completion1 December 2017
Estimated completion20 December 2017
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 19 to 39, female only, with Cesarean Section Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-diabetic pregnant women who undergo elective CS will be randomized into two groups: group I included women who has their skin closed with subcuticular interrupted mattress suture using non-absorbable polypropylene, and group II included women who has their skin closed with subcuticular continous suture using the same suture material

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Section Wound

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03120806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing